Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 10:13:781054.
doi: 10.3389/fneur.2022.781054. eCollection 2022.

Factors Associated With the Improvement of Left Ventricular Systolic Function by Continuous Positive Airway Pressure Therapy in Patients With Heart Failure With Reduced Ejection Fraction and Obstructive Sleep Apnea

Ryo Naito  1   2 , Takatoshi Kasai  1   2   3 , Tomotaka Dohi  1 , Hisashi Takaya  3 , Koji Narui  3 , Shin-Ichi Momomura  4
Affiliations

Factors Associated With the Improvement of Left Ventricular Systolic Function by Continuous Positive Airway Pressure Therapy in Patients With Heart Failure With Reduced Ejection Fraction and Obstructive Sleep Apnea

Ryo Naito et al. Front Neurol. .

Abstract

Background: Obstructive sleep apnea (OSA) is a potential risk factor in cardiovascular diseases, including arrhythmia, coronary artery disease, and heart failure (HF). Continuous positive airway pressure (CPAP) therapy is an effective therapy for OSA and the underlying HF, partly through a 5-9% increase in the left ventricular ejection fraction (LVEF). However, the data on the factors associated with the efficacy of CPAP on LVEF in patients with HF complicated by OSA are scarce. This study aimed to investigate whether LVEF improves in patients with OSA and HF after 1 month of CPAP therapy, and to clarify which factors are associated with the degree of LVEF improvement.

Method: This was a prospective, single-arm, open-label study. We enrolled moderate-to-severe patients with OSA and HF who were being followed up at the cardiovascular center of Toranomon Hospital (Tokyo, Japan). The parameters of sleep study and LVEF were assessed at the baseline and after 1 month of CPAP. The multivariate regression analyses, with changes in LVEF as a dependent variable, were performed to determine the factors that were associated with the degree of LVEF improvement.

Results: We analyzed 55 consecutive patients with OSA and HF (mean age: 60.7 ± 12.2 years, mean LVEF value: 37.2 ± 9.8%). One month of CPAP treatment decreased the apnea-hypopnea index (AHI) from 45.3 ± 16.1 to 5.4 ± 4.1 per hour, and the LVEF improved from 37.2 ± 9.8 to 43.2 ± 11.7%. The multivariate regression analyses demonstrated that age and body mass index (BMI) were significant determinants of LVEF improvement.

Conclusion: The LVEF improved significantly after 1 month of CPAP therapy in Japanese patients with OSA and HF. Multivariate regression analyses indicated that an improvement in LVEF was likely to be observed in young patients with obesity.

Keywords: CPAP; HFrEF (heart failure with reduced ejection fraction); LVEF (left ventricular ejection fraction); OSA (obstructive sleep apnea); short-term.

PubMed Disclaimer

Conflict of interest statement

RN and TK are affiliated with a department endowed by Philips Respironics, ResMed, and Fukuda Denshi. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Left ventricular ejection fraction (LVEF) improved from 37.2 to 43.2%, with a statistical significance after 1 month of CPAP treatment.
Figure 2
Figure 2
(A,B) Significant decrease in systolic and diastolic blood pressures (BP) as well as heart rate (C) after 1 month of continuous positive airway pressure (CPAP) treatment.
Figure 3
Figure 3
Serum norepinephrine concentration levels (A) decreased, and Epworth Sleepiness Scale (B) improved after 1 month of CPAP treatment, while no significant change in BMI (C) was observed.
See this image and copyright information in PMC

References

    1. Levy D, Kenchaiah S, Larson MG, Benjamin EJ, Kupka MJ, Ho KK, et al. . Long-term trends in the incidence of and survival with heart failure. N Engl J Med. (2002) 347:1397–402. 10.1056/NEJMoa020265 - DOI - PubMed
    1. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, et al. . The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. US carvedilol heart failure study group. N Engl J Med. (1996) 334:1349–55. 10.1056/NEJM199605233342101 - DOI - PubMed
    1. Jong P, Vowinckel E, Liu PP, Gong Y, Tu JV. Prognosis and determinants of survival in patients newly hospitalized for heart failure: a population-based study. Arch Intern Med. (2002) 162:1689–94. 10.1001/archinte.162.15.1689 - DOI - PubMed
    1. Chan J, Sanderson J, Chan W, Lai C, Choy D, Ho A, et al. . Prevalence of sleep-disordered breathing in diastolic heart failure. Chest. (1997) 111:1488–93. 10.1378/chest.111.6.1488 - DOI - PubMed
    1. Peker Y, Kraiczi H, Hedner J, Löth S, Johansson A, Bende M. An independent association between obstructive sleep apnoea and coronary artery disease. Eur Respir J. (1999) 14:179–84. 10.1034/j.1399-3003.1999.14a30.x - DOI - PubMed